Thin colorectal cancer patients have shorter survival than obese patients
the ONA take:
According to new findings presented today at the ESMO World Congress on Gastrointestinal Cancer in Barcelona, Spain, researchers from Duke University School of Medicine in Durham, North Carolina, have found that thin patients with colorectal cancer have shorter survival than obese patients.
For the study, researchers analyzed data from 6,128 patients who had been treated for untreated metastatic colorectal cancer. All patients received bevacizumab plus chemotherapy.
Researchers found that patients with a body mass index (BMI) between 20 and 24.9 survived a mean of 21.1 after treatment initiation compared with 23.5 months for those with a BMI of 25 to 29 and 24 months for those with a BMI of 30 to 35.
"Contrary to our hypothesis, patients who had the lowest BMI were at risk for having the shortest survival," said lead author Yousuf Zafar, M.D., associate professor of medicine at Duke University. "In this case, patients with the lowest body weight—people who had metastatic colon cancer and a BMI of less than 25—were at the highest risk."
The findings do not mean that being overweight is protective for patients with colorectal cancer undergoing treatment, but rather there could be an underlying mechanism that put thinner patients at an increased risk for poor outcomes.
Thin patients with colorectal cancer have shorter survival than obese patients.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|